What is CG Oncology's EPS (basic)?

CG Oncology (CGON) reported EPS (basic) of -$0.71 in Q1 2026.

How has CG Oncology's EPS (basic) changed year-over-year?

CG Oncology's EPS (basic) decreased by 57.8% year-over-year, from -$0.45 to -$0.71.

What is the long-term trend for CG Oncology's EPS (basic)?

Over 2 years (2023 to 2025), CG Oncology's EPS (basic) has grown at a -63.6% compound annual growth rate (CAGR), from -$15.62 to -$2.07.

What does EPS (basic) mean?

Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.

CG Oncology CGON EPS (Basic)

EPS (Basic) at other companies

PfizerPFE

$0.47-9.6%

Johnson & JohnsonJNJ

$2.17-52.5%

Gilead SciencesGILD

$1.63+53.8%

ImmunityBio, Inc.IBRX

-$0.62-313%

Cogent Biosciences, Inc.COGT

-$0.53-1.9%

Tango TherapeuticsTNGX

-$0.32+11.1%

Other financials

Income statement

See full

Revenue$1.1M+1,983%

Operating income-$66.4M-57.3%

Net income-$60.2M-74.7%

EPS (diluted)-$0.71-57.8%

Balance sheet

See full

Cash & equivalents$33.7M-18.7%

Total debt$7.6M+631%

Total equity$1.1B+54.9%

Total assets$1.1B+55.9%

Cash flow

See full

Operating cash flow-$56.9M-94.5%

CapEx$304.0K+1,800%

Free cash flow-$57.2M-95.4%

Valuation

See full

Market cap$5.39B+206%

Enterprise value$5.36B+212%

P/S1,062.4×-1,596×

Profitability

See full

Operating margin-4,239%-1,872pp

Net margin-3,682.6%-1,601pp

FCF margin-3,163.8%-1,351pp

Returns & leverage

See full

Return on equity-20.8%+7.1pp

Debt / equity0×0.0×

Current ratio31.3×+0.3×

Where this comes from

Reported directly by CG Oncology in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CG Oncology's EPS (basic)?: CG Oncology (CGON) reported EPS (basic) of -$0.71 in Q1 2026.
How has CG Oncology's EPS (basic) changed year-over-year?: CG Oncology's EPS (basic) decreased by 57.8% year-over-year, from -$0.45 to -$0.71.
What is the long-term trend for CG Oncology's EPS (basic)?: Over 2 years (2023 to 2025), CG Oncology's EPS (basic) has grown at a -63.6% compound annual growth rate (CAGR), from -$15.62 to -$2.07.
What does EPS (basic) mean?: Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.